Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Rheumatoid Arthritis

  Free Subscription


Articles published in Rheumatol Int

Retrieve available abstracts of 151 articles:
HTML format



Single Articles


    July 2022
  1. HAN P, Sun C, Zhang Y, Yan J, et al
    Sjogren's syndrome with adult-onset Still's disease: an overlap syndrome?
    Rheumatol Int. 2022;42:1281-1285.
    PubMed     Abstract available


    June 2022
  2. BOYADZHIEVA V, Tachkov K, Stoilov N, Mitov K, et al
    Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapies.
    Rheumatol Int. 2022 Jun 27. pii: 10.1007/s00296-022-05163.
    PubMed     Abstract available


  3. INGRAM T, Sengupta R, Standage M, Barnett R, et al
    Correlates of physical activity in adults with spondyloarthritis and rheumatoid arthritis: a systematic review.
    Rheumatol Int. 2022 Jun 8. pii: 10.1007/s00296-022-05142.
    PubMed     Abstract available


    May 2022
  4. HOQUE A, Steultjens M, Dickson DM, Hendry GJ, et al
    Patients' and clinicians' perspectives on the clinical utility of the Rheumatoid Arthritis Foot Disease Activity Index.
    Rheumatol Int. 2022 May 27. pii: 10.1007/s00296-022-05147.
    PubMed     Abstract available


  5. POPOVA V, Geneva-Popova M, Kraev K, Batalov A, et al
    Assessment of TNF-alpha expression in unstable atherosclerotic plaques, serum IL-6 and TNF-alpha levels in patients with acute coronary syndrome and rheumatoid arthritis.
    Rheumatol Int. 2022 May 26. pii: 10.1007/s00296-022-05113.
    PubMed     Abstract available


  6. ZEKIC T, Benic MS, Radic M
    Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease.
    Rheumatol Int. 2022 May 23. pii: 10.1007/s00296-022-05143.
    PubMed     Abstract available


    April 2022
  7. KARABULUT Y, Gezer HH, Esen S, Esen I, et al
    Tofacitinib monotherapy and erectile dysfunction in rheumatoid arthritis: a pilot observational study.
    Rheumatol Int. 2022 Apr 25. pii: 10.1007/s00296-022-05132.
    PubMed     Abstract available


  8. PAPPAS DA, Brittle C, Concoff A, Holman AJ, et al
    Perspectives on applying immuno-autonomics to rheumatoid arthritis: results from an online rheumatologist survey.
    Rheumatol Int. 2022 Apr 21. pii: 10.1007/s00296-022-05122.
    PubMed     Abstract available


  9. FEUCHTENBERGER M, Kovacs MS, Eder A, Nigg A, et al
    Methotrexate significantly reduces the humoral vaccination response against SARS-CoV-2 in older but not younger patients with rheumatoid arthritis.
    Rheumatol Int. 2022 Apr 16. pii: 10.1007/s00296-022-05123.
    PubMed     Abstract available


  10. YOSHII I, Sawada N, Chijiwa T
    Clinical characteristics and variants that predict prognosis of difficult-to-treat rheumatoid arthritis.
    Rheumatol Int. 2022 Apr 11. pii: 10.1007/s00296-022-05124.
    PubMed     Abstract available


  11. RODERE M, Pereira B, Soubrier M, Fayet F, et al
    Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis.
    Rheumatol Int. 2022 Apr 7. pii: 10.1007/s00296-022-05090.
    PubMed     Abstract available


  12. YOSHIMURA M, Fujieda Y, Sugawara M, Kono M, et al
    Disease activity as a risk factor for venous thromboembolism in rheumatoid arthritis analysed using time-averaged DAS28CRP: a nested case-control study.
    Rheumatol Int. 2022 Apr 6. pii: 10.1007/s00296-022-05121.
    PubMed     Abstract available


  13. JEON YH, Lim DH, Choi SW, Choi SJ, et al
    A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient.
    Rheumatol Int. 2022;42:743-748.
    PubMed     Abstract available


  14. ZHANG X, Yang Q, Yu H, Yin F, et al
    Bibliometric analysis of the global literature productivity of adult-onset Still's disease (2011-2020).
    Rheumatol Int. 2022;42:707-716.
    PubMed     Abstract available


    March 2022
  15. SKACELOVA M, Nekvindova L, Mann H, Zavada J, et al
    The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry.
    Rheumatol Int. 2022 Mar 26. pii: 10.1007/s00296-021-05072.
    PubMed     Abstract available


  16. NAKAYAMA Y, Watanabe R, Murakami K, Murata K, et al
    Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.
    Rheumatol Int. 2022 Mar 10. pii: 10.1007/s00296-021-05086.
    PubMed     Abstract available


  17. KABEERDOSS J, Sandhya P, Kurien BT, Scofield RH, et al
    In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren's syndrome.
    Rheumatol Int. 2022;42:545-551.
    PubMed     Abstract available


    February 2022
  18. SKRZYPKOWSKA M, Stasiak M, Sakowska J, Chmiel J, et al
    Cytokines and chemokines multiplex analysis in patients with low disease activity rheumatoid arthritis.
    Rheumatol Int. 2022 Feb 18. pii: 10.1007/s00296-022-05103.
    PubMed     Abstract available


  19. SWAIN N, Tripathy A, Padhan P, Raghav SK, et al
    Toll-like receptor-7 activation in CD8+ T cells modulates inflammatory mediators in patients with rheumatoid arthritis.
    Rheumatol Int. 2022 Feb 10. pii: 10.1007/s00296-021-05050.
    PubMed     Abstract available


  20. QIN L, Zhang Y, Yang X, Luo Q, et al
    Cardiac involvement in primary Sjgren's syndrome.
    Rheumatol Int. 2022;42:179-189.
    PubMed     Abstract available


    January 2022
  21. WILK M, Losinska K, Pripp AH, Korkosz M, et al
    Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life.
    Rheumatol Int. 2022 Jan 31. pii: 10.1007/s00296-021-05070.
    PubMed     Abstract available


  22. PSALTIS D, Settas L, Georgiadis A, Koukli E, et al
    The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study.
    Rheumatol Int. 2022 Jan 29. pii: 10.1007/s00296-021-05073.
    PubMed     Abstract available


  23. HASAN AA, Reimann F, Veeger NJGM, Bergstra SA, et al
    Optical imaging compared to clinical examination in 484 rheumatoid arthritis patients: the Leeuwarden Handscan Registry.
    Rheumatol Int. 2022 Jan 27. pii: 10.1007/s00296-021-05060.
    PubMed     Abstract available


  24. KOSTURKOVA MB, Mihaylova GM, Shivacheva TK, Radanova MA, et al
    Association of C1q gene cluster variants with rheumatoid arthritis: a pilot study.
    Rheumatol Int. 2022 Jan 13. pii: 10.1007/s00296-022-05089.
    PubMed     Abstract available


  25. KONSTANTONIS G, Singh KV, Sfikakis PP, Jamthikar AD, et al
    Cardiovascular disease detection using machine learning and carotid/femoral arterial imaging frameworks in rheumatoid arthritis patients.
    Rheumatol Int. 2022 Jan 11. pii: 10.1007/s00296-021-05062.
    PubMed     Abstract available


  26. VIDEM V, Hoff M, Liff MH
    Use of the Behavioral Regulation in Exercise Questionnaire-2 to assess motivation for physical activity in persons with rheumatoid arthritis: an observational study.
    Rheumatol Int. 2022 Jan 9. pii: 10.1007/s00296-021-05079.
    PubMed     Abstract available


  27. LAROCHE M, Degboe Y, Constantin A
    Sjogren's syndrome associated with erosive rheumatoid arthritis alters its prognosis and long-term therapeutic response: a case-control study.
    Rheumatol Int. 2022 Jan 9. pii: 10.1007/s00296-021-05074.
    PubMed     Abstract available


  28. TAYLAN A
    Rituximab therapy in pericarditis associated with rheumatoid arthritis.
    Rheumatol Int. 2022 Jan 5. pii: 10.1007/s00296-021-05080.
    PubMed     Abstract available


  29. CHEN X, Hu QY, Wang M, Jia J, et al
    Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease.
    Rheumatol Int. 2022;42:149-157.
    PubMed     Abstract available


    December 2021
  30. FRANKOWSKI M, Swierkot J, Gomulkiewicz M, Korman L, et al
    Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.
    Rheumatol Int. 2021 Dec 6. pii: 10.1007/s00296-021-05059.
    PubMed     Abstract available


  31. BAICUS C
    The stratification of primary Sjogren's syndrome: is it really solving the problem?
    Rheumatol Int. 2021;41:2241.
    PubMed    


    November 2021
  32. BALCHIN C, Tan AL, Wilson OJ, McKenna J, et al
    Participation in physical activity decreased more in people with rheumatoid arthritis than the general population during the COVID-19 lockdown: a cross-sectional study.
    Rheumatol Int. 2021 Nov 30. pii: 10.1007/s00296-021-05054.
    PubMed     Abstract available


  33. ROMERA BAURES M, Seoane-Mato D, Alegre-Sancho JJ, Leon L, et al
    Impact of rheumatoid arthritis on sexuality: adaptation and validation of the Qualisex questionnaire for use in Spain.
    Rheumatol Int. 2021 Nov 16. pii: 10.1007/s00296-021-05043.
    PubMed     Abstract available


  34. SERBAN A, Mihai A, Dima A, Balaban DV, et al
    The impact of the COVID-19 pandemic on patients with primary Sjogren syndrome.
    Rheumatol Int. 2021;41:1933-1940.
    PubMed     Abstract available


  35. DARDER A, Losada Lopez I, Gomez-Bellvert C, Rodriguez A, et al
    Pulmonary nodular lymphoid hyperplasia and Sjogren's syndrome: a case report and literature review.
    Rheumatol Int. 2021;41:2041-2044.
    PubMed     Abstract available


  36. PRIORI R, Giardina F, Izzo R, Gattamelata A, et al
    Resilience in women with primary Sjogren's syndrome.
    Rheumatol Int. 2021;41:1987-1994.
    PubMed     Abstract available


    October 2021
  37. DE COCK D, Buckinx E, Pazmino S, Bertrand D, et al
    Belgian rheumatologists' preferences regarding measures of disease activity in patients with rheumatoid arthritis: results from a mixed-methods study.
    Rheumatol Int. 2021 Oct 23. pii: 10.1007/s00296-021-05020.
    PubMed     Abstract available


  38. WOLKORTE R, Heesink L, Kip MMA, Koffijberg H, et al
    Monitoring of rheumatoid arthritis: a patient survey on disease insight and possible added value of an innovative inflammation monitoring device.
    Rheumatol Int. 2021 Oct 21. pii: 10.1007/s00296-021-05026.
    PubMed     Abstract available


  39. MORALES-ETCHEGARAY I, Garcia-Carrasco M, Munguia-Realpozo P, Mendoza-Pinto C, et al
    Changing trends in rheumatoid arthritis mortality in Mexico, from 1998 to 2017.
    Rheumatol Int. 2021 Oct 5. pii: 10.1007/s00296-021-05013.
    PubMed     Abstract available


  40. USKUDAR CANSU D, Uskudar Teke H, Korkmaz C
    Temporal artery biopsy for suspected giant cell arteritis: a retrospective analysis.
    Rheumatol Int. 2021;41:1803-1810.
    PubMed     Abstract available


  41. MITTAL GK, Mittal S, Kaur H, Stephen SR, et al
    Anti-Sjogren's-syndrome-related antigen A autoantibodies (Anti-SSA antibody) and meningoencephalitis: Sjogren's syndrome waiting to be unveiled? A case series and review of literature.
    Rheumatol Int. 2021;41:1855-1866.
    PubMed     Abstract available


    September 2021
  42. BELANI PJ, Kavadichanda CG, Negi VS
    Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial.
    Rheumatol Int. 2021 Sep 29. pii: 10.1007/s00296-021-04994.
    PubMed     Abstract available


  43. MELIKOGLU MA, Ataman S, Bodur H, Cay HF, et al
    Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR.
    Rheumatol Int. 2021 Sep 24. pii: 10.1007/s00296-021-04992.
    PubMed     Abstract available


  44. ALMUTAIRI K, Nossent J, Preen DB, Keen H, et al
    The temporal association between hospital admissions, biological therapy usage and direct health care costs in rheumatoid arthritis patients.
    Rheumatol Int. 2021 Sep 18. pii: 10.1007/s00296-021-04985.
    PubMed     Abstract available


  45. NAFFAA ME, Hassan F, Golan-Cohen A, Merzon E, et al
    Factors associated with drug survival on first biologic therapy in patients with rheumatoid arthritis: a population-based cohort study.
    Rheumatol Int. 2021 Sep 16. pii: 10.1007/s00296-021-04989.
    PubMed     Abstract available


  46. BARTELS LE, Ammitzboll C, Andersen JB, Vils SR, et al
    Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Rheumatol Int. 2021 Sep 2. pii: 10.1007/s00296-021-04972.
    PubMed     Abstract available


  47. COLLINS A, Lendrem D, Wason J, Tarn J, et al
    Revisiting the JOQUER trial: stratification of primary Sjogren's syndrome and the clinical and interferon response to hydroxychloroquine.
    Rheumatol Int. 2021;41:1593-1600.
    PubMed     Abstract available


  48. GEHIN JE, Klaasen RA, Norli ES, Warren DJ, et al
    Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort.
    Rheumatol Int. 2021;41:1657-1665.
    PubMed     Abstract available


    August 2021
  49. GONZALEZ DA, Bianchi ML, Salgado PA, Armada M, et al
    Disease activity and subcutaneous nodules are associated to severe periodontitis in patients with rheumatoid arthritis.
    Rheumatol Int. 2021 Aug 22. pii: 10.1007/s00296-021-04974.
    PubMed     Abstract available


  50. ZHAO SS, Nikiphorou E, Young A, Kiely PDW, et al
    Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status-results from the early rheumatoid arthritis study.
    Rheumatol Int. 2021 Aug 16. pii: 10.1007/s00296-021-04931.
    PubMed     Abstract available


  51. MACIVER A, Hollinger H, Carolan C
    Tele-health interventions to support self-management in adults with rheumatoid arthritis: a systematic review.
    Rheumatol Int. 2021;41:1399-1418.
    PubMed     Abstract available


    July 2021
  52. SOBEJANA M, van den Hoek J, Metsios GS, Kitas GD, et al
    Cardiorespiratory fitness and physical activity in people who have rheumatoid arthritis at an increased risk of cardiovascular disease: a cross-sectional study.
    Rheumatol Int. 2021 Jul 31. pii: 10.1007/s00296-021-04903.
    PubMed     Abstract available


  53. ZURA N, Vukorepa M, Jurak I, Peric P, et al
    Decrease in handgrip strength in rheumatoid arthritis (RA): is there a sex-related difference?
    Rheumatol Int. 2021 Jul 28. pii: 10.1007/s00296-021-04959.
    PubMed     Abstract available


  54. BARIK RR, Bhatt LK
    Emerging epigenetic targets in rheumatoid arthritis.
    Rheumatol Int. 2021 Jul 26. pii: 10.1007/s00296-021-04951.
    PubMed     Abstract available


  55. JOHNSTONE G, Treharne GJ, Fletcher BD, Lamar RSM, et al
    Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown.
    Rheumatol Int. 2021 Jul 23. pii: 10.1007/s00296-021-04952.
    PubMed     Abstract available


  56. MULLER K, Kuipers JG, Weis J, Fischer I, et al
    Self-reported fatigue in patients with rheumatoid arthritis compared to patients with cancer: results from two large-scale studies.
    Rheumatol Int. 2021 Jul 16. pii: 10.1007/s00296-021-04948.
    PubMed     Abstract available


  57. HONNE K, Bando M, Mieno MN, Iwamoto M, et al
    Bronchiectasis is as crucial as interstitial lung disease in the severe pneumonia that occurs during treatment with biologic DMARDs in rheumatoid arthritis: a retrospective cohort study in a single facility.
    Rheumatol Int. 2021 Jul 12. pii: 10.1007/s00296-021-04934.
    PubMed     Abstract available


  58. NAKAJIMA T, Watanabe R, Hashimoto M, Murata K, et al
    Neutrophil count reduction 1 month after initiating tocilizumab can predict clinical remission within 1 year in rheumatoid arthritis patients.
    Rheumatol Int. 2021 Jul 9. pii: 10.1007/s00296-021-04944.
    PubMed     Abstract available


  59. YAGIZ B, Coskun BN, Pehlivan Y, Dalkilic E, et al
    In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?
    Rheumatol Int. 2021 Jul 5. pii: 10.1007/s00296-021-04939.
    PubMed     Abstract available


  60. CHEVALLARD M, Belloli L, Ughi N, Adinolfi A, et al
    Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting.
    Rheumatol Int. 2021;41:1253-1261.
    PubMed     Abstract available


  61. MULLER R
    Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities.
    Rheumatol Int. 2021;41:1189-1202.
    PubMed     Abstract available


    June 2021
  62. OULKADI L, Rostom S, Hmamouchi I, El Hassani Sbai S, et al
    Prevalence of latent tuberculosis before biotherapy initiation in rheumatoid arthritis and spondyloarthritis: data from the Moroccan biotherapy registry.
    Rheumatol Int. 2021 Jun 26. pii: 10.1007/s00296-021-04929.
    PubMed     Abstract available


  63. GOMEZ-GALICIA DL, Aguilar-Castillo J, Garcia-Garcia C, Moctezuma-Rios JF, et al
    Qualitative validation of audiovisual educational material for use on rheumatoid arthritis patients.
    Rheumatol Int. 2021 Jun 19. pii: 10.1007/s00296-021-04921.
    PubMed     Abstract available


  64. TANAKA K, Kimura E, Oryoji K, Mizuki SI, et al
    Hypertension and dyslipidemia are risk factors for herpes zoster in patients with rheumatoid arthritis: a retrospective analysis using a medical information database.
    Rheumatol Int. 2021 Jun 6. pii: 10.1007/s00296-021-04889.
    PubMed     Abstract available


  65. SEBASTIAN A, Woytala P, Madej M, Proc K, et al
    Is it possible to not perform salivary gland biopsy in targeted patients according to unstimulated salivary flow results in patients with suspected Sjogren's syndrome?
    Rheumatol Int. 2021;41:1125-1131.
    PubMed     Abstract available


  66. WADE SD, Kyttaris VC
    Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study.
    Rheumatol Int. 2021;41:1115-1124.
    PubMed     Abstract available


    May 2021
  67. FAYET F, Pereira B, Fan A, Rodere M, et al
    Therapeutic education improves rheumatoid arthritis patients' knowledge about methotrexate: a single center retrospective study.
    Rheumatol Int. 2021 May 29. pii: 10.1007/s00296-021-04893.
    PubMed     Abstract available


  68. SOYSAL E, Ulutas F, Tepeli E, Kaymaz S, et al
    IL-23R gene polymorphisms in rheumatoid arthritis.
    Rheumatol Int. 2021 May 12. pii: 10.1007/s00296-021-04881.
    PubMed     Abstract available


  69. BHATIA A, Kc M, Gupta L
    Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions.
    Rheumatol Int. 2021;41:843-850.
    PubMed     Abstract available


  70. MIGKOS MP, Kaltsonoudis E, Pelechas E, Drossou V, et al
    Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience.
    Rheumatol Int. 2021;41:903-909.
    PubMed     Abstract available


  71. HEGEMAN MC, Schoemaker-Delsing JA, Luttikholt JTM, Vonkeman HE, et al
    Patient perspectives on how to improve education on medication side effects: cross-sectional observational study at a rheumatology clinic in The Netherlands.
    Rheumatol Int. 2021;41:973-979.
    PubMed     Abstract available


  72. MANOJ M, Sahoo RR, Singh A, Hazarika K, et al
    Prevalence of hydroxychloroquine retinopathy with long-term use in a cohort of Indian patients with rheumatic diseases.
    Rheumatol Int. 2021;41:929-937.
    PubMed     Abstract available


    April 2021
  73. KAESTNER S, Wolff HJ, Braeuer R, Kaestner P, et al
    Immunoglobulin deficiencies in treated patients suffering from rheumatoid arthritis.
    Rheumatol Int. 2021 Apr 29. pii: 10.1007/s00296-021-04871.
    PubMed     Abstract available


  74. MAEDA Y, Hirano T, Ebina K, Hara R, et al
    Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study.
    Rheumatol Int. 2021 Apr 26. pii: 10.1007/s00296-021-04862.
    PubMed     Abstract available


  75. TONGA E, Williamson E, Srikesavan C, Ozen T, et al
    A hand exercise mobile app for people with rheumatoid arthritis in Turkey: design, development and usability study.
    Rheumatol Int. 2021 Apr 18. pii: 10.1007/s00296-021-04860.
    PubMed     Abstract available


  76. LU H, Yao Y, Yang J, Zhang H, et al
    Microbiome-miRNA interactions in the progress from undifferentiated arthritis to rheumatoid arthritis: evidence, hypotheses, and opportunities.
    Rheumatol Int. 2021 Apr 15. pii: 10.1007/s00296-021-04798.
    PubMed     Abstract available


  77. CHELLAMUTHU G, Muthu S, Khanna M, Khanna V, et al
    "Platelet-rich plasma holds promise in management of rheumatoid arthritis"-systematic review.
    Rheumatol Int. 2021 Apr 8. pii: 10.1007/s00296-021-04849.
    PubMed     Abstract available


  78. ELZORKANY B, Mokbel A, Gamal SM, Hmamouchi I, et al
    Does smoking affect level of seropositivity in RA? A post-HOC global and inter-country analysis of COMORA cohort.
    Rheumatol Int. 2021;41:699-705.
    PubMed     Abstract available


  79. DEY M, Zhao SS
    Google search data as a novel adjunct to patient and public involvement in rheumatology research.
    Rheumatol Int. 2021;41:771-779.
    PubMed     Abstract available


  80. AKYOL A, Kocyigit BF
    Publication activity in the field of Sjogren's syndrome: a ten-year Web of Science based analysis.
    Rheumatol Int. 2021;41:763-769.
    PubMed     Abstract available


    March 2021
  81. CRONIN O, McKnight O, Keir L, Ralston SH, et al
    A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease.
    Rheumatol Int. 2021 Mar 15. pii: 10.1007/s00296-021-04835.
    PubMed     Abstract available


  82. YILDIRIM R, Cansu DU, Arik D, Saylisoy S, et al
    Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review.
    Rheumatol Int. 2021 Mar 9. pii: 10.1007/s00296-021-04822.
    PubMed     Abstract available


  83. MASLINSKA M, Manczak M, Kwiatkowska B, Ramsperger V, et al
    IgA immunoglobulin isotype of rheumatoid factor in primary Sjogren's syndrome.
    Rheumatol Int. 2021;41:643-649.
    PubMed     Abstract available


    February 2021
  84. PELECHAS E, Voulgari PV, Drosos AA
    Insulin resistance in patients with rheumatoid arthritis.
    Rheumatol Int. 2021 Feb 26. pii: 10.1007/s00296-021-04814.
    PubMed    


  85. ALMUTAIRI K, Inderjeeth C, Preen DB, Keen H, et al
    The accuracy of administrative health data for identifying patients with rheumatoid arthritis: a retrospective validation study using medical records in Western Australia.
    Rheumatol Int. 2021 Feb 23. pii: 10.1007/s00296-021-04811.
    PubMed     Abstract available


  86. FEUCHTENBERGER M, Kraus L, Nigg A, Schulze-Koops H, et al
    Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study).
    Rheumatol Int. 2021 Feb 20. pii: 10.1007/s00296-021-04804.
    PubMed     Abstract available


  87. VAJDIC ID, Stimac G, Pezelj I, Mustapic M, et al
    Psoas abscess during treatment with intravenous tocilizumab in a patient with rheumatoid arthritis: a case-based review.
    Rheumatol Int. 2021 Feb 12. pii: 10.1007/s00296-021-04800.
    PubMed     Abstract available


  88. ZIADE N, Saad S, Al Mashaleh M, El Kibbi L, et al
    Perceptions of patients with rheumatoid arthritis about self-assessment of disease activity after watching an educational video: a qualitative pilot study from the AUTO-DAS in Middle Eastern Arab countries project.
    Rheumatol Int. 2021 Feb 6. pii: 10.1007/s00296-021-04799.
    PubMed     Abstract available


    January 2021
  89. MATHIEU S, Pereira B, Saraux A, Richez C, et al
    Disease-modifying drug retention rate according to patient age in patients with early rheumatoid arthritis: analysis of the ESPOIR cohort.
    Rheumatol Int. 2021 Jan 12. pii: 10.1007/s00296-020-04770.
    PubMed     Abstract available


  90. GUTIERREZ J, Sandoval H, Perez-Neri I, Arauz A, et al
    Advances in imaging technologies for the assessment of peripheral neuropathies in rheumatoid arthritis.
    Rheumatol Int. 2021 Jan 11. pii: 10.1007/s00296-020-04780.
    PubMed     Abstract available


  91. MCKENNA SG, Donnelly A, Esbensen BA, Comber L, et al
    The feasibility of an exercise intervention to improve sleep (time, quality and disturbance) in people with rheumatoid arthritis: a pilot RCT.
    Rheumatol Int. 2021 Jan 2. pii: 10.1007/s00296-020-04760.
    PubMed     Abstract available


  92. FELLOUS S, Rkain H, Ahid S, Abouqal R, et al
    One-year direct costs of biological therapy in rheumatoid arthritis and its predictive factors: data from the Moroccan RBSMR registry.
    Rheumatol Int. 2021 Jan 2. pii: 10.1007/s00296-020-04762.
    PubMed     Abstract available


  93. MASIC D, Stengaard-Pedersen K, Logstrup BB, Horslev-Petersen K, et al
    Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trial.
    Rheumatol Int. 2021 Jan 2. pii: 10.1007/s00296-020-04756.
    PubMed     Abstract available


  94. GIARDINA F, Izzo R, Gattamelata A, Colafrancesco S, et al
    COVID-19 in Italian Sjogren's syndrome patients: a monocentric study.
    Rheumatol Int. 2021;41:235-236.
    PubMed    


  95. ANGELOPOULOU F, Bogdanos D, Dimitroulas T, Sakkas L, et al
    Immune checkpoint inhibitor-induced musculoskeletal manifestations.
    Rheumatol Int. 2021;41:33-42.
    PubMed     Abstract available


    December 2020
  96. GORODETSKIY VR, Sidorova YV, Kupryshina NA, Vasilyev VI, et al
    Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis.
    Rheumatol Int. 2020 Dec 5. pii: 10.1007/s00296-020-04757.
    PubMed     Abstract available


  97. LOARCE-MARTOS J, Garcia-Fernandez A, Lopez-Gutierrez F, Garcia-Garcia V, et al
    High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.
    Rheumatol Int. 2020;40:2015-2021.
    PubMed     Abstract available


    November 2020
  98. BRADY SM, Fenton SAM, Metsios GS, Bosworth A, et al
    Different types of physical activity are positively associated with indicators of mental health and psychological wellbeing in rheumatoid arthritis during COVID-19.
    Rheumatol Int. 2020 Nov 30. pii: 10.1007/s00296-020-04751.
    PubMed     Abstract available


  99. PAPPAS DA, Brittle C, Mossell JE 3rd, Withers JB, et al
    Perceived clinical utility of a test for predicting inadequate response to TNF inhibitor therapies in rheumatoid arthritis: results from a decision impact study.
    Rheumatol Int. 2020 Nov 30. pii: 10.1007/s00296-020-04746.
    PubMed     Abstract available


  100. PELECHAS E, Voulgari PV, Drosos AA
    Occupational mimics of rheumatoid arthritis: hair dye-induced arthritis.
    Rheumatol Int. 2020 Nov 16. pii: 10.1007/s00296-020-04748.
    PubMed     Abstract available


  101. KAYA SUBASI P, Guler T, Yurdakul FG, Ataman S, et al
    Carpal tunnel syndrome in patients with rheumatoid arthritis and psoriatic arthritis: an electrophysiological and ultrasonographic study.
    Rheumatol Int. 2020 Nov 13. pii: 10.1007/s00296-020-04745.
    PubMed     Abstract available


  102. ALMUTAIRI K, Nossent J, Preen D, Keen H, et al
    The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review.
    Rheumatol Int. 2020 Nov 11. pii: 10.1007/s00296-020-04731.
    PubMed     Abstract available


  103. ABUALFADL E, Ismail F, Shereef RRE, Hassan E, et al
    Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural-urban gap and north-south gradient.
    Rheumatol Int. 2020 Nov 1. pii: 10.1007/s00296-020-04736.
    PubMed     Abstract available


    October 2020
  104. ORTIZ AM, Silva Fernandez L, Villaverde V, Abad MA, et al
    Gaps between research and recommendations in rheumatoid arthritis.
    Rheumatol Int. 2020 Oct 20. pii: 10.1007/s00296-020-04724.
    PubMed     Abstract available


  105. LINDNER L, Callhoff J, Alten R, Krause A, et al
    Correction to: Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007-2017.
    Rheumatol Int. 2020 Oct 16. pii: 10.1007/s00296-020-04725.
    PubMed     Abstract available


  106. LIFF MH, Hoff M, Wisloff U, Videm V, et al
    Faster age-related decline in cardiorespiratory fitness in rheumatoid arthritis patients: an observational study in the Trondelag Health Study.
    Rheumatol Int. 2020 Oct 9. pii: 10.1007/s00296-020-04713.
    PubMed     Abstract available


  107. MONTERO F, Martinez-Barrio J, Serrano-Benavente B, Gonzalez T, et al
    Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
    Rheumatol Int. 2020;40:1593-1598.
    PubMed     Abstract available


  108. SZEWCZYK D, Sadura-Sieklucka T, Sokolowska B, Ksiezopolska-Orlowska K, et al
    Improving the quality of life of patients with rheumatoid arthritis after rehabilitation irrespective of the level of disease activity.
    Rheumatol Int. 2020 Oct 1. pii: 10.1007/s00296-020-04711.
    PubMed     Abstract available


  109. BARESIC M, Jezic I, Simetic L, Herceg D, et al
    Rituximab as a treatment option in a patient with rheumatoid arthritis and a history of malignancy-intracranial chondrosarcoma/osteochondroma-case based review.
    Rheumatol Int. 2020 Oct 1. pii: 10.1007/s00296-020-04706.
    PubMed     Abstract available


    September 2020
  110. NAGAI Y, Yokogawa N, Shimada K, Sugii S, et al
    Utility of the neutrophil-to-lymphocyte ratio for predicting bacterial infection in patients with rheumatoid arthritis receiving Tocilizumab.
    Rheumatol Int. 2020 Sep 23. pii: 10.1007/s00296-020-04705.
    PubMed     Abstract available


  111. PAPPAS DA, Litman HJ, Lesperance T, Kricorian G, et al
    Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data.
    Rheumatol Int. 2020 Sep 2. pii: 10.1007/s00296-020-04667.
    PubMed     Abstract available


    August 2020
  112. DAVERGNE T, Moe RH, Fautrel B, Gossec L, et al
    Development and initial validation of a questionnaire to assess facilitators and barriers to physical activity for patients with rheumatoid arthritis, axial spondyloarthritis and/or psoriatic arthritis.
    Rheumatol Int. 2020 Aug 30. pii: 10.1007/s00296-020-04692.
    PubMed     Abstract available


  113. JAMTHIKAR AD, Gupta D, Puvvula A, Johri AM, et al
    Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging.
    Rheumatol Int. 2020 Aug 28. pii: 10.1007/s00296-020-04691.
    PubMed     Abstract available


  114. UTHMAN I, Almoallim H, Buckley CD, Masri B, et al
    Nurse-led care for the management of rheumatoid arthritis: a review of the global literature and proposed strategies for implementation in Africa and the Middle East.
    Rheumatol Int. 2020 Aug 26. pii: 10.1007/s00296-020-04682.
    PubMed     Abstract available


  115. PENCHEVA DT, Heaney A, McKenna SP, Monov SV, et al
    Adaptation and validation of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire for use in Bulgaria.
    Rheumatol Int. 2020 Aug 19. pii: 10.1007/s00296-020-04686.
    PubMed     Abstract available


  116. REMALANTE PPM, Salido EO, Penserga EG, Gauiran DTV, et al
    Red cell distribution width and neutrophil-lymphocyte ratio in rheumatoid arthritis.
    Rheumatol Int. 2020 Aug 19. pii: 10.1007/s00296-020-04685.
    PubMed     Abstract available


  117. VAN DEN OEVER IAM, Baniaamam M, Simsek S, Raterman HG, et al
    The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis.
    Rheumatol Int. 2020 Aug 10. pii: 10.1007/s00296-020-04666.
    PubMed     Abstract available


  118. DIMITROULAS T, Baniotopoulos P, Pagkopoulou E, Soulaidopoulos S, et al
    Subclinical atherosclerosis in systemic sclerosis and rheumatoid arthritis: a comparative matched-cohort study.
    Rheumatol Int. 2020 Aug 8. pii: 10.1007/s00296-020-04677.
    PubMed     Abstract available


    July 2020
  119. HAMMOND A, Meesters J, Niedermann K, Tennant A, et al
    Cross-cultural adaptation and psychometric testing of the Dutch and German versions of the Evaluation of Daily Activity Questionnaire in people with rheumatoid arthritis.
    Rheumatol Int. 2020 Jul 26. pii: 10.1007/s00296-020-04657.
    PubMed     Abstract available


  120. VASCONCELOS LB, Silva MT, Galvao TF
    Reduction of biologics in rheumatoid arthritis: a systematic review and meta-analysis.
    Rheumatol Int. 2020 Jul 24. pii: 10.1007/s00296-020-04651.
    PubMed     Abstract available


  121. KRIL I, Havrylyuk A, Potomkina H, Chopyak V, et al
    Apoptosis and secondary necrosis of neutrophils and monocytes in the immunopathogenesis of rheumatoid arthritis: a cohort study.
    Rheumatol Int. 2020 Jul 10. pii: 10.1007/s00296-020-04642.
    PubMed     Abstract available


  122. ELGHAWY AA, Skopis M, Davis J, Bag-Ozbek A, et al
    Angiostrongyliasis infection masquerading as granulomatosis with polyangiitis: a case-based review.
    Rheumatol Int. 2020;40:1171-1176.
    PubMed     Abstract available


  123. LI R, Wan Q, Chen P, Mao S, et al
    Tocilizumab treatment in Felty's syndrome.
    Rheumatol Int. 2020;40:1143-1149.
    PubMed     Abstract available


  124. LEE SB, Choi H, Kim MK, Jung SM, et al
    Can antineutrophil cytoplasmic antibody positivity at diagnosis predict the poor outcomes of Sjogren's syndrome?
    Rheumatol Int. 2020;40:1063-1070.
    PubMed     Abstract available


    June 2020
  125. WESTHOVENS R, Connolly SE, Margaux J, Vanden Berghe M, et al
    Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study.
    Rheumatol Int. 2020 Jun 17. pii: 10.1007/s00296-020-04619.
    PubMed     Abstract available


  126. VENETSANOPOULOU AI, Pelechas E, Voulgari PV, Drosos AA, et al
    The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk.
    Rheumatol Int. 2020 Jun 10. pii: 10.1007/s00296-020-04616.
    PubMed     Abstract available


  127. CHAITIDIS N, Theocharis P, Festas C, Aritzi I, et al
    Association of rheumatoid arthritis with hearing loss: a systematic review and meta-analysis.
    Rheumatol Int. 2020 Jun 2. pii: 10.1007/s00296-020-04609.
    PubMed     Abstract available


  128. SAPUNDZHIEVA T, Karalilova R, Batalov A
    Hand ultrasound patterns in rheumatoid and psoriatic arthritis: the role of ultrasound in the differential diagnosis.
    Rheumatol Int. 2020;40:837-848.
    PubMed     Abstract available


    May 2020
  129. O'BRIEN CM, Duda JL, Kitas GD, Veldhuijzen van Zanten JJCS, et al
    Measurement of sedentary time and physical activity in rheumatoid arthritis: an ActiGraph and activPAL validation study.
    Rheumatol Int. 2020 May 29. pii: 10.1007/s00296-020-04608.
    PubMed     Abstract available


  130. MARTINEZ G, Feist E, Martiatu M, Garay H, et al
    Autoantibodies against a novel citrullinated fibrinogen peptide related to smoking status, disease activity and therapeutic response to methotrexate in cuban patients with early rheumatoid arthritis.
    Rheumatol Int. 2020 May 29. pii: 10.1007/s00296-020-04580.
    PubMed     Abstract available


  131. HARROLD LR, Shan Y, Rebello S, Kramer N, et al
    Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjogren's syndrome enrolled in a large observational US registry.
    Rheumatol Int. 2020 May 24. pii: 10.1007/s00296-020-04602.
    PubMed     Abstract available


  132. LINDNER L, Callhoff J, Alten R, Krause A, et al
    Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007-2017.
    Rheumatol Int. 2020 May 6. pii: 10.1007/s00296-020-04593.
    PubMed     Abstract available


  133. GEORGIEV T
    Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.
    Rheumatol Int. 2020;40:825-826.
    PubMed    


  134. PARK EH, Lee EY, Shin K, Kim HA, et al
    Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
    Rheumatol Int. 2020;40:791-798.
    PubMed     Abstract available


    April 2020
  135. CHUNG TT, Ko HJ, Lau CS, Chung HY, et al
    A retrospective study on the risk of tuberculosis in patients with rheumatoid arthritis.
    Rheumatol Int. 2020 Apr 21. pii: 10.1007/s00296-020-04583.
    PubMed     Abstract available


  136. SONG J, Kang S, Choi SW, Seo KW, et al
    Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs.
    Rheumatol Int. 2020 Apr 20. pii: 10.1007/s00296-020-04584.
    PubMed     Abstract available


  137. AYAN G, Esatoglu SN, Hatemi G, Hamuryudan V, et al
    Disease course and healthcare costs of a cohort of rheumatoid arthritis patients from Turkey.
    Rheumatol Int. 2020 Apr 6. pii: 10.1007/s00296-020-04574.
    PubMed     Abstract available


  138. OLAH C, Kardos Z, Kostyal L, Hodosi K, et al
    Correction to: Assessment of cervical spine involvement in rheumatoid arthritis patients in the era of biologics: a real-life, cross-sectional MRI study.
    Rheumatol Int. 2020 Apr 4. pii: 10.1007/s00296-020-04572.
    PubMed     Abstract available


  139. BENSON R, Zhao SS, Goodson N, Abernethy R, et al
    Correction to: Biologic monotherapy in the biologic naive patient with rheumatoid arthritis (RA): results from an observational study.
    Rheumatol Int. 2020 Apr 2. pii: 10.1007/s00296-020-04556.
    PubMed     Abstract available


  140. MASLINSKA M, Wojciechowska B, Manczak M, Kwiatkowska B, et al
    Serum immunoglobulin G4 in Sjogren's syndrome: a pilot study.
    Rheumatol Int. 2020;40:555-561.
    PubMed     Abstract available


  141. TRAIANOS EY, Locke J, Lendrem D, Bowman S, et al
    Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjogren's syndrome.
    Rheumatol Int. 2020;40:541-548.
    PubMed     Abstract available


    March 2020
  142. SEBASTIAN A, Madej M, Sebastian M, Butrym A, et al
    Prevalence and clinical presentation of lymphoproliferative disorder in patients with primary Sjogren's syndrome.
    Rheumatol Int. 2020;40:399-404.
    PubMed     Abstract available


  143. KIM HW, Kwon OC, Han SH, Park MC, et al
    Positive conversion of interferon-gamma release assay in patients with rheumatic diseases treated with biologics.
    Rheumatol Int. 2020;40:471-479.
    PubMed     Abstract available


  144. GORODETSKIY VR, Probatova NA, Radenska-Lopovok SG, Ryzhikova NV, et al
    Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren's syndrome patients: case series study and review of the literature.
    Rheumatol Int. 2020;40:499-506.
    PubMed     Abstract available


    February 2020
  145. BERNARDINO V, Rodrigues A, Llado A, Panarra A, et al
    Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic.
    Rheumatol Int. 2020;40:295-301.
    PubMed     Abstract available


  146. CARANDANG K, Vigen CLP, Ortiz E, Pyatak EA, et al
    Re-conceptualizing functional status through experiences of young adults with inflammatory arthritis.
    Rheumatol Int. 2020;40:273-282.
    PubMed     Abstract available


    January 2020
  147. GODA K, Kenzaka T, Hoshijima M, Yachie A, et al
    Adult-onset Still's disease with macrophage activation syndrome diagnosed and treated based on cytokine profiling: a case-based review.
    Rheumatol Int. 2020;40:145-152.
    PubMed     Abstract available


  148. RUSCITTI P, Cipriani P, Liakouli V, Iacono D, et al
    Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
    Rheumatol Int. 2020;40:107-113.
    PubMed     Abstract available


    September 2019
  149. WEI Z, Jiaying S, Junhong G
    Bilateral facial paralysis as a rare neurological manifestation of primary Sjogren's syndrome: case-based review.
    Rheumatol Int. 2019;39:1651-1654.
    PubMed     Abstract available


  150. OLSSON P, Bodewes ILA, Nilsson AM, Turesson C, et al
    Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjogren's syndrome.
    Rheumatol Int. 2019;39:1575-1584.
    PubMed     Abstract available


  151. OKU K, Atsumi T
    Rheumatology practice in Japan: challenges and opportunities.
    Rheumatol Int. 2019;39:1499-1505.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: